|
|
|
¡ã ÀÌÇö½Â ±³¼ö |
Ãæ³²´ëÇб³º´¿ø ³»ºÐºñ´ë»ç³»°ú ÀÌÇö½Â ±³¼ö°¡ 10¿ù 28ÀÏ ¼¿ï Àá½Ç ·Ôµ¥¿ùµåÈ£ÅÚ¿¡¼ ¿¸° ´ëÇѳ»ºÐºñÇÐȸ ±¹Á¦Çмú´ëȸ ‘SICEM 2023’¿¡¼ ‘¿¬±¸ º»»ó’À» ¹Þ¾Ò´Ù.
´ëÇѳ»ºÐºñÇÐȸ ¿¬±¸ º»»óÀº Áö³ 3³â°£ ±¹Á¦ÇмúÁö ³í¹® °ÔÀç ½ÇÀû°ú ¿¬±¸°èȹ¼ ¹× ÇÐȸ °øÇåµµ¸¦ ¹ÙÅÁÀ¸·Î ¸Å³â 1¸íÀÇ ³»ºÐºñ´ë»çÇÐ ÀüÀÓ±³¿ø¿¡°Ô ¼ö¿©µÇ´Â ÃÖ°í ±ÇÀ§ÀÇ Çмú»óÀÌ´Ù.
ÀÌÇö½Â ±³¼ö´Â ´ëÇѳ»ºÐºñÇÐȸ ±¹Á¦ÇмúÁö ¡ºEnM(Endocrinology and Metabolism)¡»¿¡ ‘±×·¹À̺꽺º´ ȯÀÚ°¡ °©»ó¼±±â´É Ç×ÁøÁõÀ¸·ÎºÎÅÍ Á¤»ó °©»ó¼±±â´ÉÀ¸·Î ȸº¹ÇÏ´Â °úÁ¤¿¡¼ÀÇ ´ë»çü º¯È ºÐ¼®(Metabolite Changes during the Transition from Hyperthyroidism to Euthyroidism in Patients with Graves Disease)’À̶õ Á¦¸ñÀ¸·Î °ÔÀçÇÑ ³í¹®(1ÀúÀÚ ÀÌÈ£¿± Ãæ³²´ëÇб³ ÀÇ°úÇаú ¹Ú»ç°úÁ¤/±³½ÅÀúÀÚ ÀÌÇö½Â ±³¼ö)ÀÌ ¿ÃÇØÀÇ ‘EnM Çмú»ó’¿¡ ¼±Á¤µÇ±âµµ Çß´Ù.
ÀÌÇö½Â ±³¼ö´Â “¾ÕÀ¸·Îµµ ³»ºÐºñ´ë»çÁúȯÀÇ º´Å»ý¸® ¿¬±¸¸¦ ¼öÇàÇÏ¿© ¸öÀÌ ¾ÆÇ ȯÀڵ鿡°Ô ÃÖ°í ¼öÁØÀÇ Àü¹®¼ºÀ» ±â¹ÝÀ¸·Î ÇÑ Áø·á¸¦ ÆîÄ¥ ¼ö ÀÖµµ·Ï ³ë·ÂÇÏ°Ú´Ù”¸é¼ “À̹ø ¿¬±¸°á°ú¸¦ ¹ÙÅÁÀ¸·Î ȯÀڵ鿡°Ô µµ¿òÀÌ µÉ ¼ö ÀÖ´Â »õ·Î¿î Áúȯ Ä¡·á¹°ÁúÀ» °³¹ßÇÒ °èȹÀÌ´Ù”¶ó°í ¸»Çß´Ù. |